REG3A and metabolic disease: Since Reg3 family antimicrobial peptides have been reported to shape the composition of the gut microbiota in metabolic diseases [44,45], our findings warrant further exploration into whether the modulation of STAT3 activity alters microbial communities in mouse models of IBD.